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Abstract
The present study tested the hypothesis that if polycystic ovary syndrome (PCOS) results from activating the nora-
drenergic outflow to the ovary, unilaterally sectioning the superior ovarian nerve (SON) will result in ovulation by
the denervated ovary, and the restoration of progesterone (P4), testosterone (T) and estradiol (E2) normal serum
level. A single 2 mg dose of estradiol valerate (EV) to adult rats results in the development of a syndrome similar
to the human PCOS. Ten-day old rats were injected with EV or vehicle solution (Vh) and were submitted to sham
surgery, unilateral or bilateral sectioning of the SON at 24-days of age. The animals were sacrificed at 90 to 92 days
of age, when they presented vaginal estrus preceded by a pro-estrus smear. In EV-treated animals, unilateral sec-
tioning of the SON restored ovulation by the innervated ovary and unilateral or bilateral sectioning of the SON
normalized testosterone and estradiol levels. These results suggest that aside from an increase in ovarian noradre-
nergic tone in the ovaries, in the pathogenesis of the PCOS participate other neural influences arriving to the ovar-
ies via the SON, regulating spontaneous ovulation. Changes in P4, T and E2 serum levels induced by EV treatment
seem to be controlled by neural signals arising from the abdominal wall and other signals arriving to the ovaries
through the SON, and presents asymmetry.
Background
The polycystic ovarian syndrome (PCOS) affects
approximately 3% to 5% of the female population [1]
and is the most common cause of infertility in women
of reproductive age [2-4]. PCOS is a complex disease
characterized by ovulatory failure, the presence of ovar-
ian cysts, menstrual irregularities, amenorrhea, hyperan-
drogenism and variable levels of circulating
gonadotropins [3,5]. Commonly, PCOS is accompanied
by obesity, hirsutism, and, in the vast majority of cases,
infertility [4]. PCOS may lead to complications involving
glucose metabolism, dyslipidemias, cardiovascular dis-
ease and cancer [1,2]. In women with PCOS, lowering
estradiol levels treatments with clomiphen citrate [4,6],
bilateral extirpation of a piece of the ovaries [5,7], or by
electro acupuncture treatment [8], restores ovulation
and menstrual cycles.
Treating new-born rats with testosterone propionate
(TP) or progesterone (P4) resulted in endocrine and
histological disorders, similar to those found in women
with PCOS syndrome [9]. However, data from
TP-androgenized rats showed that serum luteinizing
hormone (LH), follicle stimulating hormone (FSH),
testosterone (T) and estradiol (E2) concentrations were
similar to those in the control group [10]. Previously, we
showed that anovulatory syndrome induced by TP does
not occur if the animals had peripheral noradrenergic
denervation induced by guanethidine treatment [11].
Estradiol valerate (EV) is a long-acting estrogen, and a
single 2 mg dose to adult rats results in the development
of a syndrome characterized by loss of estrous cyclicity,
persistent vaginal cornification, anovulation, formation of
follicular cysts, alterations in basal and pulsatile LH and
FSH concentrations, and high concentrations of E2.
These symptoms are considered similar to human PCOS
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[12-16]. EV treatment to pre-pubertal female rats results
in higher E2 levels in serum, lower gonadotropins and
androstenedione concentrations in serum, and an altera-
tion in the follicular growth dynamic that favors the for-
mation of follicular cysts [17]. At the ovarian level, EV
treatment results in a higher capacity of the ovarian
nerve terminals to incorporate and release norepinephr-
ine (NE), increases in ovarian NE content and lower
ovarian b-adrenergic receptor number in the ovarian
compartments [12,13,16,17].
The bilateral sectioning of the superior ovarian nerve
(SON) to pre-pubertal and adult EV-treated rats restores
the estrous cycle and ovulation [13,17]. Based on these
and other results it has been proposed that a derange-
ment in neurogenic inputs may contribute to the devel-
opment of ovarian pathologies like the PCOS [13,16,17].
Ovulation and hormone secretion by the ovaries are
regulated by hormonal signals secreted by the hypotha-
lamic-pituitary-ovarian axis, and neural influences mod-
ulating the ovarian response to such hormonal signals
[16,18,19].
The SON and the ovarian plexus nerve provide nora-
drenergic ovarian innervations [20,21]. The bilateral sec-
tioning of the SON did not modify ovulation nor
gonadotropins levels; but compared to control groups
lowered E2 and P4 serum levels [20,22-24]. On the hand,
unilateral sectioning of the SON results in a significantly
lower ovulation capacity by the denervated ovary [23,24],
which is not restored by gonadotropins treatment [25].
In the present study we tested the hypothesis that if
PCOS results from the activation of noradrenergic out-
flow to the ovary, unilateral sectioning the SON will
restore ovulation by the denervated ovary, without mod-
ifying the lack of ovulation by de innervated one. In
addition, alterations to the estrous cycle, as well as P4,
T and E2 serum concentrations, will be normalized by
unilateral ovarian denervation.
Methods
All experiments were carried out in strict accordance
with the Mexican Law of Animal Treatment and Protec-
tion Guidelines. The Committee of the Facultad de
Estudios Superiores Zaragoza approved the experimental
protocols.
The study was performed using pre-pubertal female
rats of the CIIZ-V strain from our own breeding stock.
Animals were maintained under controlled lighting con-
ditions (lights on from 05:00 to 19:00 h); with free
access to rat chow and tap water. The number of ani-
mals in each group is indicated in table 1.
Animal treatment
Ten days old rats were injected a single dose a 0.1 ml of
corn oil (vehicle Vh) or with 2 mg of EV (Sigma Chem.
Co., St. Luis, Mo. USA) dissolved in 0.1 ml of corn oil.
When the animals reached 24 days of age, they were
allotted to one of the following groups:
Rats injected with Vh: a) with unilateral section of the
SON; b) with bilateral section of the SON; c) left
untouched until sacrifice.
Rats injected with EV: a) with unilateral section of the
SON; b) with bilateral section of the SON; c) left
untouched until sacrifice.
Sectioning of the SON and sham surgery procedures
were performed between 10:00 and 12:00 h, following
previously described methodology [17,23-25]. In brief,
animals were anesthetized with ether, a unilateral or
bilateral dorso-lateral incision, including skin and mus-
cle, was performed and the wound was subsequently
sealed. For sectioning the SON, the animals were
anesthetized with ether, a unilateral or bilateral dorso-
lateral incision, including skin and muscle, was per-
formed, and one or both ovaries were exposed. With
the aid of fine forceps, the ovarian ligament was sec-
tioned at approximately 1 cm from the ovary. The ovary
was subsequently returned to the abdominal cavity and
the wound sealed. The age of first vaginal estrus (pub-
erty), was recorded and daily vaginal smears were taken
thereafter. All the animals were sacrificed at 90-92 days
of age, presenting vaginal estrus preceded by a pro-
estrus smear (Figure 1).
Autopsy procedures
Animals were sacrificed by decapitation between 10.00
AM and noon. The blood from the trunk was collected,
allowed to clot, and centrifuged during 15 min at 3,000
RPM. The serum was stored at -20°C, until P4, T, E2,
FSH and LH levels were measured. At autopsy, the ovi-
ducts were dissected and the number of ova counted
with the aid of a dissecting microscope, as previously
[24-26]. The free movement of the ovary in the abdom-
inal cavity was used to verify the complete sectioning of
the suspensor ligament. The ovaries were excised and
processed for NE measurement as it was previously
Table 1 Mean ± SEM puberty in rats injected with vehicle
(Vh) or estradiol valerate on day 10 of age
Group n FVO Group n FVO
Vh 9 37.8 ± 0.9 EV 11 27.0 ± 0.5
Vh+left-sham 8 38.1 ± 0.8 EV-LS 8 28.3 ± 0.4
Vh+LSON 10 37.8 ± 0.4 EV-LSON 9 36.1 ± 0.8*
Vh+right sham 9 36.9 ± 0.5 EV-RS 7 33.4 ± 0.9*
Vh+RSON 11 37.5 ± 0.5 EV-RSON 10 33.0 ± 1.4*
Vh+bilateral sham 9 38.1 ± 0.4 EV-BS 7 32.0 ± 0.3*
Vh+BSON 8 37.2 ± 0.7 EV-BSON 9 35.8 ± 1.5*
*p < 0.05 vs. EV group (Kruskal-Wallis, followed by Mann-Whitney U-test)
FVO (age of first vaginal oestrus; LSON (section of the left superior ovarian
nerve); RSON (section of the right); BSON (bilateral section)
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described [27]. In brief, each ovary was homogenized in
300 μl of 0.1 M perchloric acid containing dihydroxy-
benzylamine as internal standard. NE was extracted
from homogenates by absorption in acid-washed alu-
mina, and measured using HPLC [27]. The samples
were assayed in 50 μl duplicated aliquots. The sensitivity
of the method was 0.1 ng.
Hormone measurement
Serum concentration of E2 (pg/ml), T (ng/ml) and P4
(ng/ml) were measured using radioimmunoassay, with
kits purchased from Diagnostic Products (Los Angeles,
CA, USA). The intra- and interassay coefficients of varia-
tion were 8.35% and 9.45% for P4, 8.12% and 9.28% for
E2, and 9.65% and 10.2% for T respectively. FSH and LH
(ng/ml) levels in serum were measured by the double
antibody RIA technique, employing reagents and proto-
cols kindly supplied by the NIADDK National Pituitary
Program (Bethesda, MD, USA). Intra- and inter-assay
variations were in the order of 5.1% and 6.5% for LH, and
4% and 7.9% for FSH. The results are expressed in terms
of NIADDK standards RP-2.FSH and LH.
Statistical analysis
Data on NE, P4, T, E2, FSH and LH concentrations,
were analyzed by multivariate analysis of variance
(MANOVA), followed by Turkey’s test. The age of first
vaginal oestrous and the number of ova shed by ovulat-
ing animals was analyzed using Kruskal-Wallis test, fol-
lowed by Mann-Whitney U-test. Mann-Whitney U-test
or Student’s t test were used for comparing the results
of two groups. The ovulation rate (number of ovulating
animals/number of treated one) was analyzed using
Fisher"s exact probability test or the Chi square test. A
p-value of less than 0.05 was considered significant.
Results
Compared to Vh-injected animals, EV treatment
advanced the age of first vaginal estrus (FVO) (Table 1).
Most rats injected with EV were in constant estrus.
FVO was not modified by unilateral or bilateral sham
surgery or sectioning of the SON in Vh-injected animals.
Right or bilateral sham surgery to EV-treated rats and left,
right or bilateral sectioning of the SON delayed FVO in
comparison with untouched EV-treated ones (Table 1).
EV-treated rats presented regular estrous cycles after
unilateral or bilateral sectioning of the SON. The Vh-
injected rats showed normal cycles.
None of the EV treated rats ovulated (0/11), while 9/9
of Vh-injected ones did (p < 0.01 Fisher’s exact prob-
ability test). Unilateral or bilateral sham operation to Vh
or EV treated animals did not modify spontaneous ovu-
lation (for Vh-injected 24/26 vs. 9/9, non significant
(n.s.); for EV injected 5/22 vs. 0/11 ovulated, n.s.; chi
square test).
Bilateral sectioning of the SON to Vh-injected animals
did not modify the spontaneous ovulation rate nor the
number of ova shed (8/8 vs. 9/9 n.s. Fisher’s exact prob-
ability test; 10.3 ± 1.3 vs. 7.0 ± 1.3, n.s. Mann-Whitney
U-test). Bilateral sectioning of the SON to EV-treated
animals restored ovulation in a similar way that
observed in bilaterally denervated rats injected with Vh
(ovulation rate EV+BSON 5/9 vs. Vh+BSON 8/8; n.s.
Fisher’s exact probability test; number of ova shed 6.6 ±
1.6 vs. 10.3 ± 1.3, n.s. Mann-Whitney U-test).
Taken together, the unilateral sectioning of the SON
(right or left section) to EV-treated rats resulted in
higher spontaneous ovulation by the innervated ovary
than in rats injected with EV [16/19 vs. 0/11, p < 0.01
(chi square test)].
Rats treated with Vh or EV submitted to unilateral
sectioning of the SON, showed higher ovulation rates
and number of ova shed by the innervated ovary than
by the denervated ovary (Figure 2).
Table 2 presents the hormone concentrations results
of Vh or EV injected animals with bilateral sectioning of
the SON. In Vh-injected animals, bilateral sham surgery
did not modify P4, T and E2, serum levels, while the
bilateral sectioning of the SON resulted in lower hor-
mone levels than in animals with sham surgery.
Figure 1 Experimental design.
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Compared with untouched EV-treated animals bilat-
eral-sham surgery or sectioning of the SON resulted in
lower T and E2 serum levels. P4 levels were lower in
EV-treated rats with bilateral section of the SON than
in EV-treated animals with bilateral sham operation.
Compared with untouched Vh-treated, animals EV
treatment resulted in higher T and E2 serum concentra-
tion. P4 concentration differences were not observed
between these two groups (Table 3).
Compared with untouched Vh-treated animal left or
right sham surgery to Vh-injected animals did not mod-
ify P4 levels. In comparison with Vh-injected sham-
operated rats, sectioning the left SON resulted in lower
P4 levels.
Sham operation to EV-treated animals did not modify
P4 levels in comparison with EV-treated rats. Sectioning
the left SON resulted in higher P4 levels than in EV-
sham operated animals, while in the right SON-sec-
tioned animals an inverse response occurred.
Sham operation to Vh-injected animals did not modify
T levels, while sectioning the left SON resulted in lower
hormone levels than in sham-operated rats.
In EV-treated animals, left sham-surgery resulted in
significantly lower T levels when compared to with EV-
treated ones left untouched, while the section of the left
SON resulted in lower T levels than in EV-sham oper-
ated ones.
In Vh-injected animals, unilateral sham surgery did
not modify E2 serum levels, while sectioning the right
SON resulted in lower hormone levels than in animals
with sham-surgery.
In EV-treated animals, unilateral sham surgery and






Figure 2 Ovulation rate in rats with unilateral section of the SON. Percent of ovulating rats and mean ± SEM number of ova shed in rats
injected with vehicle (Vh) or estradiol valerate (EV) at 10 days of life, submitted to unilateral section of the superior ovarian nerve, sacrificed at
day 90-92 of life. Ovulation rate * p < 0.05 vs. denervated (Fisher’s test) Number ova shed * p < 0.05 vs. denervated (kruskal-Wallis test)
Table 2 Mean ± SEM of hormone levels in vehicle (Vh) or estradiol valerate (EV) injected on day 10 of age
Group Progesterone (ng/ml) Testosterone (ng/ml) Estradiol (pg/ml)
Vh 11.4 ± 1.4 25.0 ± 6.1 21.2 ± 1.3
Vh+Sham bilateral 13.9 ± 1.3 16.1 ± 0.5 22.1 ± 1.4
Vh+BSON 9.0 ± 1.4† ND*† 15.0 ± 1.9†
EV 13.9 ± 2.4 54.5 ± 5.7 36.7 ± 5.5
EV+Sham bilateral 10.9 ± 0.9 32.1 ± 6.2§ 18.7 ± 2.0§
EV+BSON 6.6 ± 0.9#§ 27.8 ± 4.6§ 18.7 ± 1.6§
† p < 0.05 vs. Vh+sham bilateral operated group (ANOVA followed by Tukey Test)
§ p < 0.05 vs. EV group (ANOVA followed by Tukey Test)
* p < 0.05 vs. Vh group (ANOVA followed by Tukey Test)
# p < 0.05 vs. their EV+sham bilateral operated group (Student’s “t” test)
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FSH and LH levels
No significant differences in LH levels were observed. In
rats injected with EV, sectioning the L-SON resulted in
lower FSH levels than in Vh-treated rats, while bilateral
sectioning of the SON resulted in higher levels of the
FSH than in EV-injected rats (Table 4).
NE ovarian levels
NE levels were higher in both ovaries of EV-treated ani-
mals than in Vh-treated rats. Sectioning the left SON
resulted in lower NE levels in the left ovary (denervated).
Sectioning the right ovary resulted in lower NE levels in
both ovaries. The bilateral sectioning of the SON resulted
in lower NE levels in both ovaries (Table 5).
Discussion
Taken together, the results presented herein support the
idea that PCOS induced by EV treatment results from
the hyperactivity of the ovarian noradrenergic system
[16,17,28], and that the SON is one of the neural path-
ways participating in the control of the syndrome. In
addition, the effects of unilaterally sectioning the SON
suggest that the lack of ovulation in PCOS animals
depends on modifications in other neural mechanisms
regulating ovarian functions.
The ovaries receive neural information through the
SON, the ovarian plexus nerve, and the vagus nerve
[29], and it has been proposed that a neural communi-
cation between the ovaries exists [30]. It is possible that
the SON is one of the pathways communicating both
ovaries [24]. Unilateral sectioning of the SON of adult
and pre-pubertal rats results in a lack or diminution of
spontaneous ovulation by the denervated ovary, and
normal ovulation and compensatory ovulation by the
innervated ovary [23,24]. Unilateral sectioning of the
SON restored ovulation by the innervated ovary in non-
ovulating rats with the lesion of the dorsal raphe
nucleus (DRN), while the denervated ovary did not
Table 3 Mean ± SEM of hormone levels in animals injected with vehicle (Vh) or estradiol valerate (EV) and unilateral
sectioning of the SON
Group Progesterone (ng/ml) Testosterone (ng/ml) Estradiol (pg/ml)
Vh 11.4 ± 1.4 25.0 ± 6.1 21.2 ± 1.3
EV 13.9 ± 2.4 54.5 ± 5.7* 36.7 ± 5.5*
Vh+ left-sham 15.9 ± 1.8 37.5 ± 3.4 22.8 ± 2.62
Vh+LSON 8.1 ± 1.7† 16.0 ± 1.8† 23.1 ± 2.9
EV+ left-sham 9.9 ± 0.9 29.1 ± 0.3§ 16.3 ± 1. 6§
EV+LSON 16.6 ± 1.9# 17.8 ± 2.3# 15.9 ± 1.2§
Vh+ right-sham 11.5 ± 1.8 36.04 ± 7.2 21.6 ± 1.7
Vh+RSON 13.8 ± 1.5 40.9 ± 9.9 14.1 ± 1.8†
EV+ right-sham 12.3 ± 1.8 35.5 ± 12.8 20.7 ± 3.2§
EV+RSON 5.2 ± 0.6# 20.8 ± 4.4 18.1 ± 1.9§
* p < 0.05 vs. Vh group (Student’s “t” test)
† p < 0.05 vs. their Vh+sham operated group (Student’s “t” test)
# p < 0.05 vs. their EV+sham operated group (Student’s “t” test)
§ p < 0.05 vs. EV group (MANOVA followed by Tukey’s Test)
Table 4 Mean ± SEM of FSH and LH (ng/ml) levels in
animals injected with vehicle (Vh) or estradiol valerate
(EV) and unilateral or bilateral sectioning of the SON
Group FSH LH
Vh 6.1 ± 0.7 0.56 ± 0.11
EV 4.0 ± 0.7 0.38 ± 0.07
Vh+left sham 8.0 ± 0.8 0.44 ± 0.05
Vh+LSON 7.4 ± 0.5 0.40 ± 0.06
EV+left sham 4.0 ± 0.7 0.38 ± 0.07
EV+LSON 4.4 ± 0.2 0.56 ± 0.12
Vh+right sham 8.3 ± 1.3 0.43 ± 0.08
Vh+RSON 6.7 ± 1.6 0.47 ± 0.06
EV+right sham 3.4 ± 0.4 0.43 ± 0.02
EV+RSON 4.4 ± 0.5 0.45 ± 0.07
Vh+bilateral sham 5.9 ± 0.5 0.6 ± 0.06
Vh+BSON 5.3 ± 1.8 0.59 ± 0.08
EV+bilateral sham 4.2 ± 0.5 0.40 ± 0.05
EV+BSON 8.2 ± 1.5#¥ 0.39 ± 0.05
# p < 0.05 vs. EV group
¥p < 0.05 vs. EV+bilateral sham (Student’s t test)
Table 5 Mean ± SEM of norepinephrine concentration
(pg/mg of the ovary) in animals injected with estradiol
valerate (EV) and unilateral or bilateral sectioning of the
SON
Group Left Ovary Right Ovary
Control 405.5 ± 74 457.7 ± 76
EV 890 ± 140* 1103.4 ± 179*
EV LSON 155.9 ± 34* # 895.9 ± 270
EV RSON 184.3 ± 35* # < 0.1 ng*#
EV BSON 110 ± 20*# 170 ± 70* #
*p < 0.05 vs control group
#p < 0.05 vs EV group (Student’s t test)
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ovulate [31]. A similar scenario occurred in the present
study, where unilaterally sectioning the SON of rats
treated with Vh (ovulating) or EV (non-ovulating),
resulted in spontaneous ovulation by the innervated
ovary.
In rats with PCOS induced by EV-treatment, the bilat-
eral sectioning of the SON [13,16,17] or electro-acu-
puncture treatment [32] restored spontaneous ovulation.
According with the authors, the lower NE tone resulting
from sectioning the SON or the effects of electro-acu-
puncture explains such results. In rats with unilateral
sectioning of the SON, the lower NE concentration in
the denervated ovary and high or lower levels in the
innervated ovary suggest that a high NE concentration
in the ovaries of rats with PCOS, induced by EV-treat-
ment, is not the only factor explaining the PCOS.
The nerve growth factor (NGF) plays a role regulating
ovarian functions [33]. The NGF contribution to the
ovulatory process includes a stimulatory effect of the
neurotrophin on steroidogenesis, prostaglandin E2
(PGE2) formation, and proliferative activity of thecal
compartment cells [34].
In rats with PCOS induced by EV-treatment resulted
in increased intraovarian synthesis of NGF and its low
affinity receptor, p75 NGFR [34,35]. The ovarian dener-
vation induced by sectioning the SON results in an
increase in NFG concentration in the denervated ovary
[36]. The hyperactivation of ovarian sympathetic nerves
in rats with EV-induced PCOS is related to an over pro-
duction of NGF suggesting that activation of this neuro-
trophic-neurogenic regulatory loop is a component of
the pathological process by which EV induces cyst for-
mation and anovulation in rodents [12]. According to
Dissen et al., [34] an abnormally elevated production of
NGF within the ovary suffices to initiate structural and
functional alterations associated with the development
of follicular cysts in the rats’ ovaries. Then, it is possible
that these factors contribute to the development of
PCOS because, the selective blockade of NGF actions in
the ovary restored ovarian function [12]. Present results
show that unilaterally sectioning the SON results in
ovulation by the innervated ovary and the lack of ovula-
tion by the denervated one. We suppose that the block-
ade of neural communication between both ovaries
could affect the NGF concentrations in the innervated-
ovary, since an increase in NGF concentrations occurs
in the denervated ovary [36].
In the adult rat, the acute unilateral perforation of the
dorsal or ventral peritoneum results in significant and
different changes for P4, T and E2 serum levels. The
magnitude of the changes present depends on both the
side of the perforation and the day of the estrous cycle
when surgery was performed, suggesting that the neural
pathways regulating hormone ovarian secretion are not
the same for P4, T and E2 [37,38]. Present results sug-
gest that changes in ovarian hormone serum levels
induced by EV treatment seem to be controlled by
neural signals arising from the abdominal wall and other
signals.
Weiss et al., [39] suggested that the neural control of
ovarian steroidogenesis may be excitatory, mediated by
the stimulation of beta-adrenergic receptors, or inhibi-
tory, mediated through alpha-receptors.
According to Rosa-E-Silva et al [17] and Lara et al
[16], the bilateral sectioning of the SON of rats with
PCOS, induced by EV-treatment to 14 or 71 day-old
rats, normalized steroid ovarian hormone levels. In the
present study, unilateral or bilateral sectioning of the
SON of rats with PCOS induced by EV-treatment nor-
malized vaginal estrous cycles and decreased E2 levels,
suggesting that the neural information carried by the
SON plays a stimulatory role in the regulation of estra-
diol secretion.
No significant changes in FSH and LH levels are
observed in rats with PCOS induced by EV-treatment,
suggesting that abnormalities in gonadotropins levels do
not play a causal role in maintaining the polycystic con-
dition of the ovaries [14,15]. In the present study, com-
pared to EV treated rats, unilaterally sectioning the
SON of rats with PCOS did not modify FSH or LH,
supporting the idea that changes in gonadotropins levels
is not fundamental for PCOS development.
Conclusions
Taken together, our results suggest that the participa-
tion of the SON in regulating ovulation is direct in rats
with PCOS. Neural signals arriving to the ovaries via the
SON, and other signals originating from the peritoneum
and/or the abdominal wall, play a role in the regulation
of ovarian hormones secretion.
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